RMD 1.26% $38.59 resmed inc

Resmed, page-10

  1. 406 Posts.
    Respironics ( RESP ) is RMD only competitor in the APNEA disorder arena . Both control 99% of the world market . A new ( ALLEGEDLY ) entrant has been named about 6 months ago . As foreshadowed at the time , the entrant was the excuse the market used to mark RMD down from its high valuation . Period . Current weakness stemmed from general bad sentiment in the USA ( RMD is primarily an American stock ) equities markets , its past hi valuation ( not anymore though ) and a recent change in the German PBS and the recent appreciation of the A$ v US$ . RMD is the technological leader in this field . No one is even closer to its high standard . It is the "TRINTRON" of the apnea market !

    RMD will kick back big time IMHO . It is only a matter of time . Duff
 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$38.59
Change
0.480(1.26%)
Mkt cap ! $22.38B
Open High Low Value Volume
$38.50 $38.74 $38.25 $36.39M 944.5K

Buyers (Bids)

No. Vol. Price($)
1 882 $38.57
 

Sellers (Offers)

Price($) Vol. No.
$38.60 19192 6
View Market Depth
Last trade - 16.10pm 28/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.